LIBATEC®

LIBATEC® is Wacker Biotech’s technology platform for developing and manufacturing Live Microbial Products (LMPs). We developed LIBATEC® to meet our customers’ growing need for LMPs, both for clinical and market supply. Customers of the LIBATEC® platform benefit from our wealth of experience in developing and optimizing LMP processes and in GMP production.

Wacker Biotech has already manufactured a wide range of LMPs, including wild-type and genetically modified strains for use as live biotherapeutics, vaccines, immunotherapy and delivery systems for clinical and commercial use.

The LIBATEC® platform is ideal for manufacturing without hold times, and for maintaining the cell viability throughout the production process.

Advantages:

  • Over a decade of experience in LMP development and manufacturing
  • Fermentation regimes for aerobic and specific anaerobic organisms
  • Optimization of upstream and downstream processes
  • GMP-compliant drug substance manufacturing on various fermentation scales up to 1,500 liters, with integrated drug product production, including lyophilization
  • Closed production systems (monoseptic processing) in order to maintain culture purity, crucial to meeting customers’ and regulators’ quality requirements

Wacker Biotech GmbH

Hans-Knöll-Strasse 3
07745 Jena
Germany
+49 3641 5348-0

Contact Location